Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | 968 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.7 |
mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.02 | 0.7 |